Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
04/2005
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/06/2005EP0933366B1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
04/05/2005US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
04/05/2005US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides
03/2005
03/31/2005WO2005028449A1 Improved process for the manufacture of 1,2-disubstituted hexahydropyridazine-3-carboxylic acids and esters thereof
03/31/2005US20050070545 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism
03/31/2005US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
03/30/2005EP1517908A2 Novel benzimidazole derivatives
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872722 Therapies for tissue damage resulting from ischemia
03/24/2005WO2005011657A3 Piperazine derivatives and their use as therapeutic agents
03/24/2005WO2005011655A3 Pyridazine derivatives and their use as therapeutic agents
03/24/2005US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents
03/24/2005US20050065143 Pyridazine derivatives and their use as therapeutic agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005CN1597672A Substituierte benzoylcyclohexandione
03/22/2005US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869913 Pyridazin-3-one derivatives, their use and intermediates for their production
03/17/2005WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059658 N-(2,4-Difluorophenyl)-N'-[3-(4,4-dimethyl-6-oxo-1,4,5,6-tetrahydro-3-pyridazinyl)-phenyl]urea and intermediates; antiviral
03/17/2005CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/16/2005CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/09/2005EP1511737A1 Aryloximes
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/08/2005US6863838 Low melting point
03/03/2005WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509218A1 Peptide deformylase inhibitors
03/02/2005CN1191241C Pyridazinyl phenyl hydrazones useful against congestive heart failure
03/01/2005US6861532 Synthesis of 2-alkylcysteine
03/01/2005US6861428 Autoimmune disease; antiinflammatory agents; antiischemic agents; antiarthritic agents
02/2005
02/24/2005WO2005016890A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
02/24/2005WO2005016264A2 Diamine derivatives of quinone and uses thereof
02/24/2005US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
02/24/2005US20050043314 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
02/23/2005EP1507768A1 Aryl-alkyne compounds as herbicides
02/23/2005EP1507756A1 Ccr9 inhibitors and methods of use thereof
02/23/2005CN1585641A Hydrazono-malonitriles
02/23/2005CN1583727A Synthesis of fluoropyridazinone
02/22/2005CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
02/17/2005WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations
02/17/2005WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/17/2005WO2005013907A2 Pyrrolo[1,2-b]pyridazine derivatives
02/17/2005US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization
02/17/2005US20050037925 Mixture with other herbicides
02/17/2005CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/16/2005EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
02/16/2005EP1506162A2 Synthesis of benzonitriles and benzimidates
02/16/2005EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
02/16/2005CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
02/16/2005CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
02/10/2005WO2005012259A1 Method of inhibiting production of osteopontin
02/10/2005WO2005011657A2 Piperazine derivatives and their use as therapeutic agents
02/10/2005WO2005011655A2 Pyridazine derivatives and their use as therapeutic agents
02/10/2005WO2005011653A2 Pyridazine derivatives and their use as therapeutic agents
02/10/2005WO2004060860A3 Method for inhibiting the replication of herpes viruses
02/10/2005US20050033050 Phthalazinones and the use thereof in order to combat undesirable microorganisms
02/10/2005US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast
02/10/2005US20050028300 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds
02/10/2005CA2533901A1 Piperazine derivatives and their use as therapeutic agents
02/10/2005CA2533897A1 Pyridazine derivatives and their use as therapeutic agents
02/09/2005EP1503992A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
02/09/2005EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
02/09/2005EP1430047B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
02/09/2005EP1430034B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
02/09/2005EP1100789B1 Substituted benzoylcyclohexandiones
02/09/2005CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof
02/09/2005CN1188397C Process for preparation of acid chloride compounds
02/08/2005CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
02/03/2005WO2005009976A1 Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
02/03/2005WO2005009971A1 Quinolone derivative or salt thereof
02/03/2005US20050026918 Novel pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
02/03/2005DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases
02/03/2005CA2530352A1 Quinolone derivative or salt thereof
02/02/2005EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives
02/02/2005EP1501822A1 Phthalazinone derivatives
02/02/2005EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases
02/02/2005CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
02/01/2005US6849618 Herbicidal compositions for the desiccation/ defoliation of plants
02/01/2005CA2166326C Pyridazinone derivatives
01/2005
01/27/2005WO2005007632A1 Substituted pyridazinones as inhibitors of p38
01/27/2005US20050020594 Substituted pyridazinones
01/27/2005US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
01/27/2005US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
01/26/2005EP1082303B1 Heterocyclic derivatives which inhibit factor xa
01/26/2005CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
01/26/2005CN1569842A Process for preparing hexahydropyridazine-3-carboxylic acid derivatives
01/26/2005CN1186327C Bannamycin
01/25/2005US6846958 Synthesis of benzimidate from benzoic acid
01/25/2005CA2170637C Pyridazinone derivatives or their salts, processes for their production, and anti-shock agents containing them
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 85